At a glance
ClinicalIndex Comparison RecordN/ACompleted· 184 enrolled
Drug / intervention
Total Hip Arthroplastydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Controlled Multi-Center Study on M2a Magnum Total Hip Arthroplasty
In Brief
A clinical study evaluating Total Hip Arthroplasty for Degenerative Joint Disease and Avascular Necrosis. Completed, enrolled 184 participants across 1 site.
Detailed Summary
The purpose of this study includes the investigation of Metal-ion release and Renal Function analysis in M2a Total Hip Arthroplasty.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDegenerative Joint Disease, Avascular Necrosis
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2009
First PostedNov 2009
Primary CompletionFeb 2017
Study CompletionApr 2017
TodayJul 2026
First PostedNov 10, 2009
Enrollment StartNov 1, 2009
Primary CompletionFeb 28, 2017
Study CompletionApr 28, 2017
TodayJul 2, 2026
Enrollment to primary: 7.3 yearsPosted 16.6 years ago
Interventions
Total Hip Arthroplastydevice
Degenerated hip is replaced with implantable devices, which include femoral stem, acetabular cup, femoral head and acetabular liner(control group only).